Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study-Reference-Cited by-同舟云学术

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

Published:2016-11 Issue:3 Volume:1 Page:207-216
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Domingo Enric,Freeman-Mills Luke,Rayner Emily,Glaire Mark,Briggs Sarah,Vermeulen Louis,Fessler Evelyn,Medema Jan Paul,Boot Arnoud,Morreau Hans,van Wezel Tom,Liefers Gerrit-Jan,Lothe Ragnhild A,Danielsen Stine A,Sveen Anita,Nesbakken Arild,Zlobec Inti,Lugli Alessandro,Koelzer Viktor H,Berger Martin D,Castellví-Bel Sergi,Muñoz Jenifer,de Bruyn Marco,Nijman Hans W,Novelli Marco,Lawson Kay,Oukrif Dahmane,Frangou Eleni,Dutton Peter,Tejpar Sabine,Delorenzi Mauro,Kerr Rachel,Kerr David,Tomlinson Ian,Church David N

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. From human genome to cancer genome: the first decade;Wheeler;Genome Res,2013

2. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

3. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations;Hyman;N Engl J Med,2015

4. Precision oncology: an overview;Garraway;J Clin Oncol,2013

5. DNA polymerase epsilon and delta exonuclease domain mutations in endometrial cancer;Church;Hum Mol Genet,2013

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Third-line treatment and beyond in metastatic colorectal cancer: What do we have and what can we expect?;Critical Reviews in Oncology/Hematology;2024-10

2. The game-changing impact of POLE mutations in oncology—a review from a gynecologic oncology perspective;Frontiers in Oncology;2024-08-22

3. The genomic landscape of 2,023 colorectal cancers;Nature;2024-08-07

4. Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?;Current Oncology Reports;2024-07-30

5. Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis;Frontiers in Immunology;2024-07-19